Carcinoma of the penis primary prevention

	Carcinoma of the penis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carcinoma of the Penis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carcinoma of the penis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carcinoma of the penis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carcinoma of the penis primary prevention
CDC on Carcinoma of the penis primary prevention
Carcinoma of the penis primary prevention in the news
Blogs on Carcinoma of the penis primary prevention
Directions to Hospitals Treating Carcinoma of the penis
Risk calculators and risk factors for Carcinoma of the penis primary prevention

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine

Overview

Effective measures for the primary prevention of carcinoma of the penis include circumcision, good personal hygiene, and safer sexual practices. Gardasil vaccine is recommended for men to prevent HPV infection.

Primary Prevention

Effective measures for the primary prevention of penile cancer include:^[1]

Circumcision
Good personal hygiene
Safer sexual practices such as:

Abstinence
Limiting the number of sexual partners
Use of condoms to prevent HPV infection

Vaccine

A quadri-valent vaccine to prevent HPV infection, Gardasil, has been developed, successfully tested and approved for women by the US Food and Drug Administration.^[2]Approval for men is expected in 2008. It is licensed and in production, and could substantially reduce the incidence of HPV infection in men, the incidence of genital warts and ano-genital cancers including penile cancer, and mortality.^[3]

References

↑ Cancer - penis. MedlinePlus 2015. https://www.nlm.nih.gov/medlineplus/ency/article/001276.htm
↑ Crum C, Jones C, Kirkpatrick P (2006). "Quadrivalent human papillomavirus recombinant vaccine". Nat Rev Drug Discov. 5 (8): 629–30. doi:10.1038/nrd2117. PMID 16918020.
↑ Lehtinen M, Paavonen J (2004). "Vaccination against human papillomaviruses shows great promise". Lancet. 364 (9447): 1731–2. doi:10.1016/S0140-6736(04)17410-2. PMID 15541429.

Template:WikiDoc Sources

[1] Cancer - penis. MedlinePlus 2015. https://www.nlm.nih.gov/medlineplus/ency/article/001276.htm

[pmid16918020-2] Crum C, Jones C, Kirkpatrick P (2006). "Quadrivalent human papillomavirus recombinant vaccine". Nat Rev Drug Discov. 5 (8): 629–30. doi:10.1038/nrd2117. PMID 16918020.

[pmid15541429-3] Lehtinen M, Paavonen J (2004). "Vaccination against human papillomaviruses shows great promise". Lancet. 364 (9447): 1731–2. doi:10.1016/S0140-6736(04)17410-2. PMID 15541429.

[1]

[2]

[3]